These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28364994)

  • 1. Can Managed Care Manage Polypharmacy?
    Stefanacci RG; Khan T
    Clin Geriatr Med; 2017 May; 33(2):241-255. PubMed ID: 28364994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypharmacy Reduction Strategies: Tips on Incorporating American Geriatrics Society Beers and Screening Tool of Older People's Prescriptions Criteria.
    Levy HB
    Clin Geriatr Med; 2017 May; 33(2):177-187. PubMed ID: 28364990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A literature review: polypharmacy protocol for primary care.
    Skinner M
    Geriatr Nurs; 2015; 36(5):367-371.e4. PubMed ID: 26122964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy: the challenge for nurses.
    Kaufman G
    Nurs Stand; 2016 May; 30(39):52-60. PubMed ID: 27224631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews.
    Fillit HM; Futterman R; Orland BI; Chim T; Susnow L; Picariello GP; Scheye EC; Spoeri RK; Roglieri JL; Warburton SW
    Am J Manag Care; 1999 May; 5(5):587-94. PubMed ID: 10537865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments.
    Stewart D; Mair A; Wilson M; Kardas P; Lewek P; Alonso A; McIntosh J; MacLure K;
    Expert Opin Drug Saf; 2017 Feb; 16(2):203-213. PubMed ID: 27885844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geriatric Polypharmacy: Two Physicians' Personal Perspectives.
    Chen Z; Buonanno A
    Clin Geriatr Med; 2017 May; 33(2):283-288. PubMed ID: 28364996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
    Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
    Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rules for improving pharmacotherapy in older adult patients: part 1 (rules 1-5).
    Wooten JM
    South Med J; 2015 Feb; 108(2):97-104. PubMed ID: 25688894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-related problems in the elderly].
    Bor A; Matuz M; Doró P; Viola R; Soós G
    Orv Hetil; 2012 Dec; 153(49):1926-36. PubMed ID: 23204299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study.
    Ahmed B; Nanji K; Mujeeb R; Patel MJ
    PLoS One; 2014; 9(11):e112133. PubMed ID: 25402452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deprescribing to Reduce Medication Use: Will This Help Your Patient?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2016 Nov; 54(11):21-24. PubMed ID: 27805712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA.
    Sheikh-Taha M; Dimassi H
    BMC Cardiovasc Disord; 2017 Jul; 17(1):189. PubMed ID: 28716041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of deprescribing on patients' adherence to medications.
    Reeve E; Wiese MD
    Int J Clin Pharm; 2014 Feb; 36(1):26-9. PubMed ID: 24242974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty, polypharmacy and deprescribing.
    Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing: a new goal focused on the patient.
    Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
    Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Best practices to reduce the risk of drug-drug interactions: opportunities for managed care.
    Fanciullo GJ; Washington T
    Am J Manag Care; 2011 Sep; 17 Suppl 11():S299-304. PubMed ID: 21999763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of Drug Prescription and Medication Management in Older Adults with Cardiovascular Disease.
    Wenger NK; Doherty CL; Gurwitz JH; Hirsch GA; Holmes HM; Maurer MS; Murray MD
    Drugs Aging; 2017 Nov; 34(11):803-810. PubMed ID: 29110264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy: overdosing on good intentions.
    Berenbeim DM
    Manag Care Q; 2002; 10(3):1-5. PubMed ID: 12476658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.